A controlled trial of tranexamic acid (TA) treatment for reduction of bleeding during acute myeloid leukemia (AML) induction and consolidation

Institutes of Hematology, The Chaim Sheba Medical Center, Tel-Hashomer and Hadassah Medical Center, Jerusalem, Israel

Blood. 1993;82:547a.. Abstract No. 2174.
Study details